688180 君实生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资758,39649.36%507,776223,334242,576492,639
投资性房地产0--0000
固定资产2,180,886-1.81%2,221,0972,281,0612,431,8561,894,631
在建工程2,835,15110.24%2,571,7031,858,5641,325,3571,043,664
无形资产541,900-3.19%559,774521,405546,965316,094
商誉0--0000
其他非流动资产2,679,98529.83%2,064,2731,613,7791,225,0391,594,984
8,996,31813.52%7,924,6236,498,1435,771,7925,342,012

流动资产
货币资金2,732,2794.50%2,614,5752,502,2013,788,1936,030,741
应收账款743,75446.86%506,445509,817483,226238,186
存货498,818-12.96%573,110584,471538,053599,021
其他流动资产1,230,39461.14%763,575687,328761,603348,536
5,205,24516.77%4,457,7044,283,8175,571,0757,216,484

流动负债
短期借款742,23923.05%603,197678,106452,435351,362
应付票据0--004,6720
应付帐款1,113,437-2.56%1,142,7151,232,6841,381,1451,057,457
其他流动负债1,035,4780.30%1,032,366583,134600,145357,492
2,891,1544.06%2,778,2782,493,9242,438,3981,766,311
流动资产净值2,314,09237.79%1,679,4251,789,8933,132,6785,450,173
资产总额减流动负债11,310,41017.77%9,604,0498,288,0378,904,46910,792,186

非流动负债
长期借款3,421,95222.49%2,793,6081,979,6801,195,794839,582
应付债券997,417--0000
其他非流动负债739,577-1.89%753,847376,227388,065176,143
5,158,94645.43%3,547,4552,355,9071,583,8591,015,725

总权益
    实收股本1,026,6900.00%1,026,690985,690985,690982,872
    储备项目4,917,047-1.73%5,003,7454,874,7346,165,5348,500,755
股东权益5,943,737-1.44%6,030,4345,860,4247,151,2249,483,626
非控股权益207,726694.06%26,16071,705169,386292,834